MDS Virtual Congress 2020 Archives - Page 101 of 149

Parkinson’s disease patients at Hoehn and Yahr stage 1 show deficits in reactive but not proactive inhibitory control

V. Di Caprio, N. Modugno, C. Mancini, E. Olivola, G. Mirabella (Pozzilli, Italy)
Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?

A.S Nordvig, R.N Alcalay, J.M Berger, K. Marder, G. Karsenty, A. Wang (New York, NY, USA)
Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank

D. Belete, B. Jacobs, J. Bestwick, C. Blauwendraat, S. Bandres-Ciga, K. Heilbron, R. Dobson, M. Nalls, A. Singleton, J. Hardy, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)
Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort

Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)
Parkinson’s Disease in the Middle East, North Africa and South Asia: A Scoping Review

H. Khalil, J. Siddiqui, L. Chahine, Z. Aldaajani, M. Abu Al-Melh, F. Abdullah, H. Amer, M. Ben Djebara, M. Salari, S. Khan, W. Regragui, M. Abu Snineh, S. Mittat, J. Bajwa (Irbid, Jordan)
Parkinson’s Disease patients with diplopia exhibit visuospatial and visuoperceptive impairment

W. Naumann, J. Gogarten, S. Schoenfeld, F. Klostermann, F. Marzinzik, K. Schindlbeck (Berlin, Germany)
Parkinson’s disease polygenic risk prediction and haplotype analysis in a South American cohort

D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, M. Inca-Martinez, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Lopes Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Baltimore, MD, USA)
Parkinson’s disease polygenic risk score and brain structure in neurologically healthy individuals

N. Abbasi, L. Krohn, U. Vainik, Z. Gan-Or, A. Dagher (Montreal, QC, Canada)
Parkinson’s disease-related pattern using resting-state functional MRI: Validation and refinement

A. Rommal, A. Vo, K. Schindlbeck, S. Peng, A. Greuel, M. Ruppert, C. Eggers, D. Eidelberg (Manhasset, NY, USA)
Parkinson’s Foundation Physical Therapy Faculty Program Evaluation

M. Rafferty, L. Hoffman, L. King, T. Ellis, F. Horak (Chicago, IL, USA)